13F HOLDINGS REPORT
Foresite Capital Management V, LLC
Quarter ended Q2 2025 · Filed August 12, 2025 · Accession 0001104659-25-076820
Total Value
$80.7M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG Oncology, Inc. | CGON | 1,004,050 | $26.1M | 32.34% |
| 2 | Alumis Inc | ALMS | 5,779,348 | $17.3M | 21.48% |
| 3 | Disc Medicine, Inc. | IRON | 299,069 | $15.8M | 19.62% |
| 4 | Hims & Hers Health, Inc. | HIMS | 273,151 | $13.6M | 16.87% |
| 5 | Maze Therapeutics Inc | MAZE | 345,191 | $4.2M | 5.25% |
| 6 | Lyell Immunopharma Inc | LYEL | 406,652 | $3.6M | 4.45% |